Research Opportunity

This systematic review and meta-analysis examines the prognostic significance of residual ductal carcinoma in situ (DCIS) following neoadjuvant chemotherapy in patients with triple-negative breast cancer. By synthesizing evidence from published studies, the review aims to evaluate its association with local recurrence, disease-free survival, overall survival, and other oncologic outcomes to clarify its impact on prognosis and guide surgical and adjuvant treatment decision-making.

Click-Here-(Apply Form).com
__________________________________

Authorship & Contribution Policy

Medical Research Spot follows the International Committee of Medical Journal Editors (ICMJE) recommendations.
Authorship is awarded only to contributors who fulfill all four ICMJE criteria, Medical Research Spot follows the ICMJE Recommendations for Defining the Role of Authors and Contributors.

including:

• Making a substantial scientific contribution to the project.
• Drafting or critically revising the manuscript.
• Approving the final manuscript before submission.
• Accepting responsibility for the integrity of the work.

Contributors who do not meet these requirements may be acknowledged but will not be listed as authors.
__________________________________

Research Integrity

Medical Research Spot is committed to ethical, transparent, and responsible scientific research.

• Manuscripts are prepared in accordance with internationally recognized reporting guidelines appropriate to the study design (e.g., PRISMA, STROBE, CARE, and other EQUATOR guidelines where applicable).
• All manuscripts are submitted to independent peer-reviewed journals. Editorial decisions, peer review, acceptance, and indexing remain solely at the discretion of the journal.

Disclaimer: Participation in a project does not guarantee authorship, journal acceptance, publication, or indexing. All outcomes are subject to journal policies and editorial review.